Globus Medical EV/EBIT GMED

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2013.

Today, Oct 23, 2026: 16.3×
10-year median: 27.0×
Against its 10-year history: 6th; percentile: 0 is its lowest day, 100 its highest
10-year range: 11.1× to 72.1×
Peer median: 19.2×

Globus Medical's EV/EBIT is 16.3× as of Oct 23, 2026.

That is below its ten-year median of 27.0×, lower than on 94% of days in the last ten years.

Over that time it ranged from 11.1× in Nov 2016 to 72.1× in Jan 2025.

The median for 10 medical instruments and supplies stocks of a similar size is 19.2×.

EV/EBIT over time

median 27×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	16.3×	14.8×	30.9×
2025	28.9×	23.4×	72.1×
2024	64.8×	32.4×	66.4×
2023	33.3×	17.0×	33.6×
2022	30.3×	23.4×	33.1×
2021	30.0×	25.9×	48.9×
2020	46.7×	19.6×	46.8×
2019	32.5×	19.0×	32.5×
2018	20.5×	20.0×	30.2×
2017	23.9×	13.2×	23.9×
2016	13.2×	11.1×	15.3×
2015	16.8×	13.4×	18.0×
2014	16.3×	12.6×	19.9×
2013	15.1×	10.6×	15.1×

Against its peers

Companies in Medical - Instruments & Supplies nearest Globus Medical's size, closest first, today.

Company	EV/EBIT
GMEDGlobus Medical	16.3×
ALGNAlign Technology	16.2×
PODDInsulet	20.4×
COOCooper Companies	17.2×
PENPenumbra	65.8×
SOLVSolventum	8.4×
MSAMSA Safety	18.0×
MMSIMerit Medical Systems	28.6×
HAEHaemonetics	26.8×
VNTVontier	10.9×
BMIBadger Meter	26.2×
Peer median	19.2×

Where Globus Medical ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Globus Medical

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.